The Complete PCT Research Guide: Clomid vs Tamoxifen vs Enclomiphene vs HCG
A comprehensive breakdown of HPG axis restoration compounds — mechanism, clinical data, and protocol design for PCT research.
What is PCT Research?
Post-cycle therapy (PCT) research investigates the pharmacological restoration of the hypothalamic-pituitary-gonadal (HPG) axis following suppression. The HPG axis generates the LH/FSH pulses that drive endogenous testosterone production — exogenous androgen exposure suppresses this via negative feedback on GnRH neuron output from the hypothalamus.
PCT research asks: which compounds restore HPG axis signalling most effectively, most quickly, and with the fewest adverse effects?
Mechanism Comparison
| Compound | Class | Primary Mechanism | LH Response | Speed of Action |
|---|---|---|---|---|
| Clomiphene (Clomid) | Mixed SERM | ER antagonism in hypothalamus removes negative feedback → increases GnRH → LH/FSH rise | Strong | Moderate (2–4 weeks) |
| Tamoxifen (Nolvadex) | Pure SERM | ER antagonism at pituitary and hypothalamus → LH/FSH elevation | Moderate | Moderate (2–4 weeks) |
| Enclomiphene | Pure SERM (trans isomer) | Trans-isomer of clomiphene — ER antagonism without oestrogenic (zuclomiphene) side effects | Strong | Fast (1–2 weeks) |
| Raloxifene | SERM (SERD-like) | ER antagonism at breast/hypothalamus, partial agonist at bone | Moderate | Moderate |
| HCG | LH analog | Direct Leydig cell LH receptor stimulation — bypasses HPG axis | N/A (direct) | Very fast (days) |
Clomiphene: The Research Standard
Clomiphene citrate is the most extensively researched SERM for HPG axis restoration. It is a racemic mixture of two stereoisomers with opposing activities:
Enclomiphene (trans-isomer): Pure ER antagonist — removes negative feedback on the hypothalamus, increasing GnRH pulse frequency and LH/FSH output.
Zuclomiphene (cis-isomer): Partial ER agonist — provides mild oestrogenic activity that can blunt the full antagonist effect and contribute to visual disturbances in some research models.
Tamoxifen vs Clomiphene: Key Differences
Both are SERMs acting on ER in the hypothalamus and pituitary, but their profiles differ in ways relevant to research protocol design:
| Factor | Tamoxifen | Clomiphene |
|---|---|---|
| Oestrogenic activity | Minimal | Has zuclomiphene cis-isomer (partial agonist) |
| Liver effects | Mild hepatotoxicity possible at high doses | Lower hepatotoxic potential |
| LH response | Moderate increase | Higher LH response at comparable doses |
| Half-life | ~5–7 days (active metabolite endoxifen ~14 days) | ~5–7 days |
| Research preference | When oestrogen-sensitive tissues need ER blockade | When maximum LH stimulation is the endpoint |
Enclomiphene: The Emerging Research Tool
Enclomiphene citrate (the pure trans-isomer) has completed Phase 3 trials for secondary hypogonadism — representing the most clinically advanced pure SERM for HPG restoration research. Key findings from Phase 3 data: testosterone restoration to eugonadal range within 2 weeks with maintained spermatogenesis, in contrast to exogenous testosterone which suppresses spermatogenesis.
For HPG axis research where the goal is clean LH/FSH stimulation without zuclomiphene interference, enclomiphene is the most research-pure tool available.
Frequently Asked Questions
What is the difference between Clomid and Nolvadex for PCT research?
Clomid (clomiphene) produces higher LH responses but contains the zuclomiphene cis-isomer with partial ER agonist activity. Tamoxifen (Nolvadex) is a cleaner ER antagonist at the pituitary/hypothalamus without the agonist component. Research protocol choice depends on whether maximum LH stimulation (Clomid) or cleaner ER blockade (Tamoxifen) is the priority.
Why is enclomiphene preferred over standard clomiphene in newer research?
Enclomiphene is the pure trans-isomer of clomiphene — all the HPG-axis-stimulating ER antagonism with none of the zuclomiphene partial agonist confound. Phase 3 data shows testosterone restoration equivalent to TRT while maintaining spermatogenesis — making it research-relevant for hypogonadism models.
What role does HCG play in PCT research?
HCG (human chorionic gonadotropin) is an LH analog that directly stimulates Leydig cells — bypassing the HPG axis entirely. It restores testicular testosterone production and volume without requiring hypothalamic/pituitary signalling. Research often combines HCG (for direct Leydig stimulation) with a SERM (for HPG axis restoration) to address both levels simultaneously.
Are these PCT compounds available for research from QSC?
Yes — QSC stocks Clomid, Tamoxifen, Enclomiphene, Raloxifene, HCG, Cabergoline, Arimidex, Exemestane, Letrozole, and Aromasin at ≥99% HPLC purity with Janoshik COA. All available via the PCT Research Hub.
PCT Research Hubs at QSC
Clomid Research Hub →
Tamoxifen Research Hub →
Enclomiphene Research Hub →